Close Menu

NEW YORK – Oxford Immunotec on Tuesday reported a 70 percent decline in second-quarter revenues, driven in part by the impact of COVID-19 on testing demand.

For the three months ended June 30, the company posted revenues of $5.8 million compared to $19.6 million in the year-ago period, in line with analysts' estimates.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.